What we do
About us
News & events
Investors
Careers
What we do
About us
News & events
Investors
Overview
Press releases
Events & presentations
Corporate Governance
Shareholder & stock info
Financial reports
Financial calendar
Rights Issue and Directed Issue 2023
Careers
Back
Back
Mendus announces positive survival data from Phase 2 ADVANCE II trial evaluating vididencel as maintenance therapy for AML at ASH 2023
7:30:00 PM
Keep reading
Mendus AB: REPORT FROM THE EXTRAORDINARY GENERAL MEETING OF MENDUS AB (PUBL) ON 13 DECEMBER 2023
Read